News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Oncolytics files for clinical trial, stock rises (Reuters Securities) Shares of Oncolytics Biotech Inc. rose on Friday after the company applied to the U.S. Food and Drug Administration to initiate clinical trials testing Reolysin on patients with brain cancer. - Mar 08 1:43 PM ET


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)



Website: http://biz.yahoo.com/rf/020308/n08181687_1.html

Posted on: 03/09/2002

Oncolytics files for clinical trial, stock rises

TORONTO, March 8 (Reuters) - Shares of Oncolytics Biotech Inc. (Toronto:ONC.TO - news) rose on Friday after the company applied to the U.S. Food and Drug Administration to initiate clinical trials testing Reolysin on patients with brain cancer.

Oncolytics shares were up 25 Canadian cents, or 8 percent, to C$3.25 on the Toronto Stock Exchange.

The company performed a study with Reolysin on mice in 2001 that resulted in complete tumor regression in 87 percent of the mice, and increased survival and body weight.

Reolysin is a treatment for recurrent malignant glioma, the most aggressive form of brain cancer. In a release the company said 40,000 patients in North America and Europe experience malignant brain tumors.

In January, Oncolytics filed for a clinical trial application with Health Canada. The design of the program, which will evaluate the safety and efficacy of intracerebral administration of Reolysin, will be disclosed after approval from Health Canada.

($1 equals $1.58 Canadian)



Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740